Status | Study |
Completed |
Study Name: Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome Condition: Raynaud Syndrome Date: 2011-02-01 Interventions: Drug: vardenafil 10 mg p.o. bi |
Completed |
Study Name: Botulinum Toxin in the Treatment of Raynaud's Condition: Raynaud's Syndrome Date: 2010-11-02 Interventions: Drug: botulinum toxin A Botulinum toxin A will be injected into participants hand total 40units |
Completed |
Study Name: PF-00489791 For The Treatment Of Raynaud's Condition: Raynaud's Disease Peripheral Vascular Disease Date: 2010-03-18 Interventions: Drug: PF-00489791 Subjects wit |
Completed |
Study Name: Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms Condition: Raynaud Disease Date: 2009-06-26 Interventions: Drug: 0.9% nitroglycerin in TAM cream |
Completed |
Study Name: Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma Condition: Raynaud Disease Date: 2008-02-21 Interventions: Drug: Tadalafil Tablets Tadalafil, 20 mg, alternate days, 6 weeks |
Completed |
Study Name: Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease Condition: Raynaud's Disease Date: 2007-09-11 Interventions: Drug: SLx-2101 Drug: Placebo |
Completed |
Study Name: Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon Condition: Raynaud's Disease Date: 2007-05-29 Interventions: Drug: Nitroglycerin |
Completed |
Study Name: Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon Condition: Raynaud's Disease Scleroderma Date: 2007-01-04 Interventions: Drug: Topical AmphiMatrix with nitroglycerin (MQX-503) |
Completed |
Study Name: St. John's Wort in the Treatment of Raynaud's Phenomenon Condition: Raynaud's Disease Date: 2006-07-11 Interventions: Drug: St. John's Wort SJW in c |
Completed |
Study Name: Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon Condition: Raynaud's Disease Date: 2005-12-15 Interventions: Drug: Topical organogel with nitroglycerin |